Chronic News and Research

RSS

Many cancers caused by infections

Cancer -- popularly understood as a result of mutations or mistakes within the genetic code in cells -- is also caused by infections from viruses, bacteria and parasites.

5 Dec 2007

Caraco Pharmaceutical Labs announces FDA approval to market generic Norvasc

Caraco Pharmaceutical Laboratories has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg (Amlodipine).

5 Dec 2007

Research institutes from Finland and Singapore develop remote healthcare services

VTT Technical Research Centre of Finland and A*STAR Agency for Science, Technology and Research from Singapore have developed remote healthcare services that allow patients to be treated globally independent of time and location and irrespective of the solutions provided by hardware and data system suppliers. In Finland, the first trial services for treating cardiac patients and patients suffering from chronic illnesses have been promising.

5 Dec 2007

University of Sydney to lead international anorexia study

An international treatment trial for sufferers of chronic anorexia nervosa involving Sydney, London and Chicago is a world first.

5 Dec 2007

UCSF Medical Center advances brain disorder treatment with noninvasive radiosurgery tool

The most advanced noninvasive, radiosurgery tool for treating a variety of brain disorders--including tumors--is now being used by specialists at UCSF Medical Center.

4 Dec 2007

Positive results from trial of investigational anti-epilepsy drug Brivaracetam

UCB has announced data demonstrating that anti-epileptic drug (AED) brivaracetam, with the proposed trade name Rikelta, administered as an adjunctive treatment in adults with refractory epilepsy with partial onset seizures, significantly reduced seizure frequency and had a side-effect profile comparable to placebo.

4 Dec 2007

Re-engineered Gleevec reduces heart risks

Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib - best known by its brand name Gleevec - to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect.

4 Dec 2007

Quality-improvement initiatives lead to progress in diabetes care

Two major initiatives designed to improve primary care treatment of type 2 diabetes have yielded significant benefits in largely minority, disadvantaged populations, according to a pair of studies in the December issue of Medical Care.

4 Dec 2007

Research may lead to more effective sunscreens

Chronic exposure to the sun increases the risk of an individual developing skin cancer because UV light from the sun can cause genetic mutations that enable cells in the skin to grow in an uncontrolled manner.

4 Dec 2007

Mini transplant patients' outcomes similar using related and unrelated donor cells

People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

4 Dec 2007

Modified form of imatinib becomes more specific

Imatinib (marketed as Gleevec in the US and Glivec in Europe and Australia) is used to treat various cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).

4 Dec 2007

Lymphatic vessel and lymph node function are restored with growth factor treatment

The frequent spread of certain cancers to lymph nodes often necessitates surgery or radiation therapy that damages the lymphatic system and can cause lymphedema, a condition of localized fluid retention that often increases susceptibility to infections.

4 Dec 2007

Pediatric Daytime Sleepiness Scale (PDSS) reliable in measuring impact of sleep disorders on teens' academic performance

The Pediatric Daytime Sleepiness Scale (PDSS) is an independent, reliable tool in predicting the negative impact of a sleep-related breathing disorder and daytime sleepiness on a teenager's academic performance, according to a study published in the December 1 issue of the journal SLEEP.

3 Dec 2007

Study looks at sleep deprived nurses and driving

Hospital staff nurses who work extended hours, work at night, struggle to remain awake at work, or obtain less sleep are more likely to experience a drowsy driving episode, according to a study published in the December 1 issue of the journal SLEEP.

3 Dec 2007

Benefits of ibuprofen shown to outweigh risks of gastrointestinal bleeding in children with cystic fibrosis

Treatment with ibuprofen is associated with a significantly slower rate of decline in lung function in children and adolescents with cystic fibrosis, according to a new study.

3 Dec 2007

Contaminated pet food from China caused the deaths of more than 300 cats and dogs

A new survey has revealed that contaminated pet food imported from China may have killed more than 300 dogs and cats early this year.

3 Dec 2007

Medical marijuana wins the day in court

Police in California have been ordered by a court to return a man's marijuana to him.

3 Dec 2007

Study of the post-transplant effects of alcohol use among lung donors

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

2 Dec 2007

Vermillion issued U.S. patent for method to aid diagnosis of nephrotic syndrome

Vermillion, Inc. has announced that the United States Patent Office (USPTO) has issued Vermillion U.S. Patent No. 7,297,556 for aiding diagnosis of nephrotic syndrome, a kidney disorder marked by very high or low levels of protein in the urine, which results in bodily swelling and high cholesterol.

29 Nov 2007

Bacteria cheat on their mates for own good

Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.

29 Nov 2007

Chronic News and Research

Many cancers caused by infections

Caraco Pharmaceutical Labs announces FDA approval to market generic Norvasc

Research institutes from Finland and Singapore develop remote healthcare services

University of Sydney to lead international anorexia study

UCSF Medical Center advances brain disorder treatment with noninvasive radiosurgery tool

Positive results from trial of investigational anti-epilepsy drug Brivaracetam

Re-engineered Gleevec reduces heart risks

Quality-improvement initiatives lead to progress in diabetes care

Research may lead to more effective sunscreens

Mini transplant patients' outcomes similar using related and unrelated donor cells

Modified form of imatinib becomes more specific

Lymphatic vessel and lymph node function are restored with growth factor treatment

Pediatric Daytime Sleepiness Scale (PDSS) reliable in measuring impact of sleep disorders on teens' academic performance

Study looks at sleep deprived nurses and driving

Benefits of ibuprofen shown to outweigh risks of gastrointestinal bleeding in children with cystic fibrosis

Contaminated pet food from China caused the deaths of more than 300 cats and dogs

Medical marijuana wins the day in court

Study of the post-transplant effects of alcohol use among lung donors

Vermillion issued U.S. patent for method to aid diagnosis of nephrotic syndrome

Bacteria cheat on their mates for own good

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News